Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.430
+0.090 (2.07%)
At close: Jul 2, 2026, 4:00 PM EDT
4.431
+0.001 (0.02%)
After-hours: Jul 2, 2026, 7:17 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $230.03 million as of July 2, 2026. Its market cap has increased by 721.01% in one year.
Market Cap
230.03M
Enterprise Value
132.94M
1-Year Change
721.01%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $230.03M, an increase of 10.30%. That is a compound annual growth rate of 5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 230.03M | -27.67% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 236.80M |
| Atrium Therapeutics | 233.49M |
| Nkarta | 230.38M |
| Alector | 228.71M |
| Voyager Therapeutics | 228.39M |
| Protara Therapeutics | 228.19M |
| Whitehawk Therapeutics | 225.35M |
| NervGen Pharma | 225.15M |